No results for ‘’
Link Pharma Chem Ltd
₹27.26
(0.96%)
Mon, 27 Jul 2026, 04:49 am
Process Industries
Chemicals: Specialty
24.5KLink Pharma Chem Price to Sales Ratio (P/S)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 4.17 | 15.86 | 5.58 | 9.57 | 6.72 | 0 | 8.57 | 25.75 | 10.76 | 16.80 | 7.97 | 9.68 | 9.50 | 24.85 | 0 | 0 |
| Price to book ratio | 0.21 | 0.40 | 0.38 | 0.28 | 0.27 | 0.32 | 0.53 | 0.56 | 0.68 | 1.25 | 1.07 | 0.66 | 0.84 | 1.23 | 1.08 | 1.36 | 1.19 |
| Price to sales ratio | 0.15 | 0.33 | 0.27 | 0.16 | 0.17 | 0.15 | 0.25 | 0.41 | 0.36 | 0.52 | 0.45 | 0.30 | 0.30 | 0.33 | 0.42 | 0.63 | 0.59 |
| Price to cash flow ratio | 2.93 | 2.77 | 0 | 0.91 | 0 | 3.83 | 66.95 | 0 | 4 | 3.86 | 11.30 | 2.84 | 2.38 | 0 | 0 | 0 | 7.61 |
| Enterprise value | 6.52Cr | 8.96Cr | 11.74Cr | 9.96Cr | 11.51Cr | 12.32Cr | 13.99Cr | 10.2Cr | 10.38Cr | 14.76Cr | 13.5Cr | 9.07Cr | 9.31Cr | 23.38Cr | 24.82Cr | 27.82Cr | 20.73Cr |
| Enterprise value to EBITDA ratio | 16.65 | 5.31 | 93.08 | 5.67 | 5.32 | 5.27 | 0 | 51.51 | 4.07 | 5.31 | 6.59 | 2.63 | 2.97 | 6.67 | 9.13 | 0 | 159.47 |
| Debt to equity ratio | 0.59 | 0.59 | 0.94 | 0.74 | 0.88 | 0.85 | 1.29 | 0.60 | 0.55 | 0.28 | 0.25 | 0.31 | 0.29 | 0.44 | 0.58 | 0.67 | 0.46 |
| Return on equity % | 0 | 10.23 | 2.47 | 5.16 | 2.88 | 4.97 | -23.07 | 6.83 | 2.58 | 11.92 | 6.53 | 8.71 | 9.04 | 13.92 | 4.43 | -9.48 | -7.79 |
Link Pharma Chem Ltd Price to Sales Ratio
The Link Pharma Chem Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Link Pharma Chem Ltd's valuation, profitability, and overall financial performance. Tracking the Link Pharma Chem Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Link Pharma Chem Ltd (NSE: , BSE: 524748) is currently trading at ₹27.26, with a market capitalization of ₹11.99Cr. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Link Pharma Chem Ltd Price to Sales Ratio is essential for fundamental analysis.
Link Pharma Chem Ltd Price to Sales Ratio Current Value
The current Link Pharma Chem Ltd Price to Sales Ratio stands at 0.59.
The Link Pharma Chem Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Link Pharma Chem Ltd Price to Sales Ratio Historical Trend
The Link Pharma Chem Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 0.59
- 2023: 0.63
- 2022: 0.42
- 2021: 0.33
- 2020: 0.30
The decline in Link Pharma Chem Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.
What Link Pharma Chem Ltd Price to Sales Ratio Indicates for Investors
The Link Pharma Chem Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Link Pharma Chem Ltd Price to Sales Ratio Analysis Summary
The Link Pharma Chem Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Link Pharma Chem Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Link Pharma Chem Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.